Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer
- PMID: 34452557
- PMCID: PMC8629450
- DOI: 10.31557/APJCP.2021.22.8.2445
Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer
Abstract
Background and aim: Tripartite Motif Containing 16 (TRIM16) is a member of the TRIM protein family which is known to play a suppressor role in development of numerous tumor types. However, a positive correlation between TRIM16 expression and gastric cancer (GC) progress has created a controversial situation that need to be fully delineated. The aim of this study was to assess the expression level of TRIM16 mRNA and its relationship with β-catenin, CyclinD, and BCL2 expression in Iranian GC patients and to investigate its possible association with patients' overall survival. Materials and Methods: The expression level of TRIM16 of fresh primary tumor and adjacent normal tissues in 40 GC patients was evaluated by real-time quantitative PCR method. Moreover, patients were subdivided into high or low expression subgroups based on the TRIM16 expression levels. The relationship between TRIM16 expression level, β-catenin, Cyclin D, BCL2, some clinicopathological data and prognosis of GC patients was also analyzed.
Results: qPCR analysis showed a lower level of TRIM16 in GC tissues (fold change=0.351) in comparison to their matched adjacent noncancerous tissues (p <0.001). Contrary to this, the expression levels of β-catenin, Cyclin D, and BCL2 genes were up-regulated in cancerous samples. This may explain the tumor suppressive function of TRIM16 in GC; as reduction in TRIM16 expression leads to the accumulation of mRNAs from β-catenin, Cyclin D, and BCL2 genes and eventually cancer progression. We did not observe any significant correlation between TRIM16 expression and patients' overall survival. Univariate Cox regression analysis indicated that anemia, weight loss, bleeding, stomach ache, and smoking are statistically associated with overall survival; while, multivariate analysis did not support any correlation. Conclusions: In sum, this study suggests a tumor suppressive role for TRIM16 in gastric cancer and proposes it as a potential candidate for GC prognosis.<br />.
Keywords: Overall survival; TRIM16; tripartite motif-containing 16, gastric cancer.
Figures
Similar articles
-
Changes in the Expression of Long Non-Coding RNA SDMGC and Its Target Gene, TRIM16, in Patients with Gastric Cancer.J Gastrointest Cancer. 2023 Mar;54(1):44-50. doi: 10.1007/s12029-021-00791-y. Epub 2022 Jan 3. J Gastrointest Cancer. 2023. PMID: 34978663
-
The Role and Mechanism of TRIM Proteins in Gastric Cancer.Cells. 2024 Dec 19;13(24):2107. doi: 10.3390/cells13242107. Cells. 2024. PMID: 39768197 Free PMC article. Review.
-
TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.Cancer Biol Ther. 2020;21(3):203-212. doi: 10.1080/15384047.2019.1679554. Epub 2019 Nov 21. Cancer Biol Ther. 2020. PMID: 31747856 Free PMC article.
-
Decreased expression of TRIM3 gene predicts a poor prognosis in gastric cancer.J Gastrointest Cancer. 2022 Mar;53(1):179-186. doi: 10.1007/s12029-020-00563-0. Epub 2021 Jan 7. J Gastrointest Cancer. 2022. PMID: 33415720
-
The Role of Tripartite Motif Family Proteins in Chronic Liver Diseases: Molecular Mechanisms and Therapeutic Potential.Biomolecules. 2024 Aug 21;14(8):1038. doi: 10.3390/biom14081038. Biomolecules. 2024. PMID: 39199424 Free PMC article. Review.
Cited by
-
Clinical significance of TRIM29 expression in patients with gastric cancer.Gastroenterol Hepatol Bed Bench. 2022 Spring;15(2):131-138. Gastroenterol Hepatol Bed Bench. 2022. PMID: 35845310 Free PMC article.
-
Changes in the Expression of Long Non-Coding RNA SDMGC and Its Target Gene, TRIM16, in Patients with Gastric Cancer.J Gastrointest Cancer. 2023 Mar;54(1):44-50. doi: 10.1007/s12029-021-00791-y. Epub 2022 Jan 3. J Gastrointest Cancer. 2023. PMID: 34978663
-
The Role and Mechanism of TRIM Proteins in Gastric Cancer.Cells. 2024 Dec 19;13(24):2107. doi: 10.3390/cells13242107. Cells. 2024. PMID: 39768197 Free PMC article. Review.
-
Clinical Significance of TRIM44 Expression in Patients with Gastric Cancer.Asian Pac J Cancer Prev. 2022 May 1;23(5):1725-1731. doi: 10.31557/APJCP.2022.23.5.1725. Asian Pac J Cancer Prev. 2022. PMID: 35633558 Free PMC article.
-
Multifaceted role of TRIM28 in health and disease.MedComm (2020). 2024 Nov 11;5(11):e790. doi: 10.1002/mco2.790. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39534556 Free PMC article. Review.
References
-
- Arjmand MH, Moradi A, Akbari A, et al. Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis. Cytokine. 2020;125:154869. - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Cambiaghi V, Giuliani V, Lombardi S, et al. In: TRIM proteins in cancer. TRIM/RBCC Proteins., editor. Springer; 2012. pp. 77–91. - PubMed
-
- Cheung BB, Bell J, Raif A, et al. The estrogen-responsive B box protein is a novel regulator of the retinoid signal. J Biol Chem. 2006;281:18246–56. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous